LabKey collaborators at the O'Connor Lab (University of Wisconsin—Madison) were featured in a recent Washington Post article, sharing insights from on-going Zika virus research.
Fast Co. Design has released an article featuring LabKey collaborator Artefact and the recently launched CAVD DataSpace project. The CAVD DataSpace portal is a LabKey Server-based "hypothesis engine" and visualization tool, designed in collaboration with Seattle-based design firm Artefact to facilitate open science and collaborative research.
LabKey collaborators at the O'Connor Lab (University of Wisconsin-Madison) were recently featured on NPR, sharing details about their current work researching the Zika virus and decision to share research data with the public in real-time.
JAMA Pediatrics has released an article authored by LabKey collaborator Dave O'Connor highlighting "Real-Time Sharing of Zika Virus Data in an Interconnected World." In the piece, O'Connor shares about the development…
LabKey collaborators at the O'Connor Lab (University of Wisconsin-Madison) were recently featured on NPR, sharing details about their current work researching the Zika virus and decision to share research data with…
A new article in the Fred Hutch News, Easing cancer’s heavy financial burden, covers both the Hutch Institute for Outcomes Research (HICOR) 2015 Value in Cancer Care (VCC) Summit and the debut of HICOR IQ.
A new article in the Fred Hutch News, Easing cancer’s heavy financial burden, covers both the Hutch Institute for Outcomes Research (HICOR) 2015 Value in Cancer Care (VCC) Summit and the debut of HICOR IQ.
GeekWire article featuring Argos, a tool developed by LabKey in collaboration with the Hutch. The Fred Hutchinson Cancer Research Center launched a new application today to make it easier for doctors and researchers…
GeekWire article featuring Argos, a tool developed by LabKey in collaboration with the Hutch.
We congratulate the Immune Tolerance Network (ITN) on ITN TrialShare's debut in the New England Journal of Medicine (NEJM). TrialShare has received recognition for how it provides public, interactive access to de-identified data, analyses and figures for published clinical trials.